SEC Form 4 · accession 0001104659-15-066079
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chen Schor
Officer — President and CEO · Director
Period of report
Sep 16, 2015
Accepted (ET)
Sep 18, 2015 · 6:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157601
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $2.02 | Sep 16, 2015 | A | 500,000 | A | — | Sep 16, 2025 | Common Stock | 500,000 | 500,000 | D |
Explanation of responses
- F1The option vests as to 25% of the shares on September 16, 2016 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter, provided the Reporting Person remains employed by the Issuer on such date.